4.3 Article

COVID-19 screening using breath-borne volatile organic compounds

Journal

JOURNAL OF BREATH RESEARCH
Volume 15, Issue 4, Pages -

Publisher

IOP Publishing Ltd
DOI: 10.1088/1752-7163/ac2e57

Keywords

COVID-19; exhaled breath; biomarkers; volatile organic compounds (VOCs); propanol; acetone; machine learning

Funding

  1. NSFC Distinguished Young Scholars Fund [21725701]
  2. National Natural Science Foundation of China (NSFC) Grant [22040101]
  3. Guangzhou Laboratory [EKPG21-02]

Ask authors/readers for more resources

The rapid screening of COVID-19 is crucial and can be achieved by analyzing breath-borne volatile organic compounds (VOC) with machine learning. The developed technology shows high precision in distinguishing COVID-19 from other respiratory infections, providing a novel concept for non-invasive rapid point-of-care-test screening for COVID-19 in various scenarios.
Rapid screening of COVID-19 is key to controlling the pandemic. However, current nucleic acid amplification involves lengthy procedures in addition to the discomfort of taking throat/nasal swabs. Here we describe potential breath-borne volatile organic compound (VOC) biomarkers together with machine learning that can be used for point-of-care screening of COVID-19. Using a commercial gas chromatograph-ion mobility spectrometer, higher levels of propanol were detected in the exhaled breath of COVID-19 patients (N = 74) and non-COVID-19 respiratory infections (RI) (N = 30) than those of non-COVID-19 controls (NC)/health care workers (HCW) (N = 87), and backgrounds (N = 87). In contrast, breath-borne acetone was found to be significantly lower for COVID-19 patients than other subjects. Twelve key endogenous VOC species using supervised machine learning models (support vector machines, gradient boosting machines (GBMs), and Random Forests) were shown to exhibit strong capabilities in discriminating COVID-19 from (HCW + NC) and RI with a precision ranging from 91% to 100%. GBM and Random Forests models can also discriminate RI patients from healthy subjects with a precision of 100%. In addition, the developed models using breath-borne VOCs could also detect a confirmed COVID-19 patient but with a false negative throat swab polymerase chain reaction test. It takes 10 min to allow an entire breath test to finish, including analysis of the 12 key VOC species. The developed technology provides a novel concept for non-invasive rapid point-of-care-test screening for COVID-19 in various scenarios.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available